Quantcast
Viewing latest article 2
Browse Latest Browse All 2

Promising future for r84

Image may be NSFW.
Clik here to view.
Dr. Martin Welschof is a co-founder and Managing Director of Affitech A/S. Affitech laboratories are in the Oslo Research Park. (Photo courtesy of Affitech)
Affitech tests exciting new anti-cancer drug candidate John Erik Stacy, 22 Feb 2011 Affitech has an exciting anti-cancer drug candidate, now known simply as r84, shown to fight cancer growth in animal trials. Like Avastin (Genentech), Herceptin (Roche), Erbitux (Merck) and other new anticancer drugs, r84 is a monoclonal antibody. This type of drug continues […]

Viewing latest article 2
Browse Latest Browse All 2

Trending Articles